Background: We aim to assess the predictive value of serum neuron-specific enolase (NSE) level in patients with acute ischemic stroke referring to the emergency department. Methods: This systematic review and meta-analysis performed, considering the PRISMA and MOOSE statement guidelines. A computerized literature search of the known medical database conducted by using the relevant keywords. We included studies published before November 2016 in which stroke patients compared with non-stroke controls and also studies evaluating the serum levels of NSE in the study groups. Statistical analysis was pooled in a random effect model analysis using the Comprehensive Meta-Analysis software. Results: We included 12 articles in the qualitative and quantitative analysis, that their quality acceptable based on the Newcastle Ottawa Scale (NOS scale). The pooled effect estimates showed that NSE is significantly higher in ischemic stroke patients in comparison with their controls with a high effect estimate [OR 9.68, 95% CI (3.06 to 30.6)]. The effect estimate remained statistically significant under the fixed and random effects model. Conclusion: Our results show higher levels of NSE in patients with stroke than in the control group, indicating that NSE plays a role in the diagnosis of stroke. In terms of prognosis, there is evidence regarding the direct and indirect relationship; and it founded that serum levels of NSE is higher in larger stroke volume, which needs further research. Keywords: Ischemia; Meta-analysis; Phosphopyruvate hydratase; Predictive value of tests; Stroke Citation: Najmi E, Bahbah EI, Negida A, Afifi A, Baratloo A. Diagnostic value of serum neuron-specific enolase level in patients with acute ischemic stroke; a systematic review and meta-analysis.
Introduction
Acute ischemic stroke is one of the severe diseases, considering the fifth leading cause of mortality and morbidity in the United States. It reported that 1 of every 20 persons is dying due to this disease, and every 4 minutes, someone dies due to stroke. [1] [2] [3] [4] Timely diagnosis results from proper history taking and neurological examinations, but still, there is an active role for paraclinical and radiological evaluation so can make the diagnosis, prognosis, and outcome prediction. [5] [6] [7] [8] [9] Investigations have been conducted to assess the probable role of serum biomarkers for various aspects of stroke subject, from diagnosis to outcome prediction, and research is still on. Neuron-specific enolase (NSE) is the one, probably taken into consideration more than the others. It is a glycolytic catalyze enzyme, present in neuronal, neuroendocrine tissues, and cerebrospinal fluid (CSF). 10 Kansal et al reported that its measurement in CSF might assist in the diagnosis of neurodegenerative diseases, such as Creutzfeldt-Jacob and ischemic stroke. 11 Recently, studies provide evidence regarding the possible correlation between ischemic stroke and elevation of serum NSE. [12] [13] [14] Anand et al. investigated time to increase the serum level of NSE in the case of middle cerebral artery occlusion. 15 Singh et al reported that NSE level is significantly high in patients with severe neurological deficit than the groups of mild or moderate. 16 Besides, the study of Lu et al demonstrates that after treatment of ischemic stroke, there is a strong correlation between the reduction of NSE serum level and good prognosis. 17 It seems that the role of serum biomarkers, including NSE, for diagnosis of stroke has been previously taken into account; but it is still vague. In this systematic review and meta-analysis, we aim to assess the diagnostic value of serum NSE level in patients with acute ischemic stroke, to weigh whether its level could consider as a diagnostic factor or not? 
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Literature Search Strategy A computerized literature search of the known medical database of PubMed, EMBASE, ISI Web of Sciences, CINAHL and Scopus using the following keywords: ((Phosphopyruvate Hydratase) OR (Neuron Specific Enolase)) AND "Stroke"). We included studies published in English before November 2016 in which stroke patients compared with non-stroke controls and also studies evaluating the serum levels of NSE in the study groups.
Study Selection
Two authors independently screened the literature search results for relevant studies. All studies published before November 2016 included. In the first step, titles and abstracts of the retrieved records screened, and then full-text articles of selected papers at the first step were evaluated. Any disagreement between the two reviewers resolved by discussion with a third reviewer.
Eligibility Criteria
(1) Studies whose population was patients with stroke compared with non-stroke controls; (2) studies evaluating the serum levels of NSE in the study groups; (3) studies that were described as observational studies, whether prospective or retrospective, evaluating NSE in stroke and non-stroke patients. We excluded animal studies and also studies whose data were not reliable for analysis.
Data Extraction
Data were extracted independently by 2 reviewers to a uniform data extraction sheet. The extracted data includes (1) characteristics of the study design of included studies, (2) characteristics of the study population, and (3) data of the study outcomes.
Risk of Bias Across Studies
To explore the publication bias across studies, we constructed funnel plots to present the relationship between effect size and precision. Evidence of publication bias was assessed by (1) the Egger's regression test, and (2) the trim and fill method.
Synthesis of Results
The prognostic value of NSE in stroke patients presented in observational studies in different formats. Studies reported their outcomes as (1) the mean difference and variance between the stroke group and the control group, (2) correlation coefficient between NSE and stroke, or (3) binary data as odds ratios with their 95% CI. The Cohen's (d) effect size and its variance computed from all studies according to equations provided in the Introduction to meta-analysis. Then the Cohen's (d) effect size was converted into the log point estimate (odds ratio) and its variance. Finally, the log (OR) and its variance were pooled in a random effect model analysis using the Comprehensive Meta-Analysis software. Heterogeneity assessed by the Cochrane Q test, chi-square test for the Q statistics distribution, and the I-square test. The trim and fill method was used to investigate small study effects and the possibility of publication bias.
Results

Study Selection
The primary literature search resulted in 1300 records, and finally, 12 articles with a total of 970 patients included in the meta-analysis. 13, 14, 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] Of the excluded studies, there were two relevant articles (Cunningham et al 31 and Wunderlich et al 32 ) as they reported the effect estimates in figures whose data could not be extracted and were not reliable for analysis. The PRISMA flow diagram of the current study has shown in Figure 1 .
Characteristics and Quality of Included Studies
Baseline characteristics of these studies summarized in Table 1 . The quality of included studies was acceptable, according to the Newcastle Ottawa Scale (NOS). Figure 2 shows the forest plot of the OR of NSE in stroke vs. control cases with 95% CI under the fixed and random effect models. The pooled effect estimates showed that NSE is significantly higher in ischemic stroke patients compared to their controls with a high effect estimate (OR 9.68, 95% CI [3.06 to 30.6]). The effect estimate remained statistically significant under the fixed and random effects model. Figure 3 shows the funnel plot of standard error by point (log) of NSE in stroke vs. control cases with the standard error of under the random effect model. It showed no evidence of publication bias. The trim and fill method gave the same effect estimate suggesting no small study effects.
The Correlation Between NSE and Stroke
Discussion
The current meta-analysis aimed to clarify whether there was any significant difference in NSE levels between stroke patients and control. Our findings show that NSE serum levels are considerably higher in stroke patients journals.sbmu.ac.ir/Neuroscience http compared to their controls.
Stroke is an emergency medical condition which threatens the patient's life and causes high levels of disability and mortality all over the world. In response to stroke, brain cells produce particular changes, such as releasing specific neuronal markers into the circulation and increasing neuronal isoenzymes levels, which results in brain damage. The central nervous system insult is evaluated by several neurobiochemical markers which have a standard role in the diagnosis and management of stroke patients with neurological side effects. NSE a neuronal form of the intracytoplasmic glycolytic enzyme enolase is one of these markers. Several studies have verified that NSE can be discovered in the peripheral blood of stroke patients and could be a useful marker for acute ischemic stroke.
Likewise, the conclusion of our meta-analysis is in agreement with Anand et al 15 who conducted a systematic review in 2005 consisted of 597 patients, and reported that NSE was considerably higher in stroke patients in comparison with control. They also showed that NSE significantly correlated with infarct volume, however, it did not correlate with functional outcome, and there was no clear relationship between NSE and stroke severity. Also, a systematic review by Ahmed et al 33 confirmed that NSE positively correlated with subacute infarct volume.
These results are consistent with the findings of nine out of the 12 included studies in the current meta-analysis, which showed that NSE levels were meaningfully higher in stroke patients than in the control group while, other three included studies showed no significant difference between NSE and control. 28, 34, 35 This contrast might be explained by the slow released of NSE from damaged tissue to peripheral blood. In terms of functional outcomes, included studies used different methods to assess functional outcomes such as Barthel index, Lindley scale, modified Rankin Scale (mRS), Glasgow Outcome Score, and activities of daily living scale. Three studies 22, 32, 35 reported a notable correlation between NSE and functional outcome. Moreover, Pandey et al, 14 and Bharosay et al 25 concluded that the higher the NSE level, the more significant functional worsening. However, Shahrokhi et al showed no significant difference between NSE serum concentrations and clinical outcome. 36 Using different evaluation scales and the small sample size included might explain this contrast.
Nine included studies 14, 16, [22] [23] [24] [25] [26] [27] [28] used the National Institutes of Health Stroke Scale (NIHSS) to evaluate the neurological status and stroke severity. All of them reported a notable correlation between NIHSS scores and NSE levels.
Two studies reported on NSE levels at the onset of a stroke. Oh et al 23 found that the initial NSE was significantly higher in stroke patients than control within less than 24 hours. Wunderlich et al., 32 with a total of 66 patients, reported that NSE levels showed a first rise 2-3 hours after onset of the first stroke symptoms, but they did not compare that with control levels.
Regarding infarct volume, four included studies 23, 28, 30, 32 demonstrated a significant correlation between NSE and infarct volume. Brea et al 28 involved patients with acute ischemia and patients with intracerebral hemorrhage and showed that 37 who showed that NSE was more in patients with hemorrhagic stroke than infarct stroke.
Strength Points
The present meta-analysis demonstrated no heterogeneity regarding the significant effect of NSE on stroke between the included studies. The effect estimate was consistent under the fixed and random effects model. Additionally, the funnel plot method showed no evidence of publication bias. The trim and fill method gave the same effect estimate of meta-analysis, suggesting no small study effects, this indicates that our results are highly consistent and reliable.
Limitations
Study limitations come back to the variations between the included studies in defining the period of acute stroke, the measures of functional outcomes, the severity of stroke scales, and the methods of NSE concentrations. Also, 2 studies were excluded due to unreliable data extraction from them, as they reported the effect estimates in figures whose data could not be extracted and were unreliable for analysis.
Conclusion
Our results show higher levels of NSE in patients with stroke than in the control group, indicating that NSE plays a role in the diagnosis of stroke. In terms of prognosis, there is evidence regarding the direct and indirect relationship; and it founded that serum levels of NSE is higher in larger stroke volume, which needs further research.
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